Europe
This deal is an expansion of an existing discovery collaboration. Immunocore will head the first-in-human clinical trial of the drug alone and in combination with Genentech’s checkpoint inhibitor Tecentriq (atezolizumab).
2018 Integrated Performance Report Shows Improvement on Environmental Stewardship and Diversity Aspirational Goals
The Extraordinary General Meeting (the “EGM”) of Immunicum AB (publ), reg. no 556629-1786, was held today.
FDA-Approved Study Furthers Medtronic Commitment to Generate Meaningful Clinical Evidence for Use of Renal Denervation to Treat Uncontrolled Hypertension
Trial Results Anticipated First Half 2019
Quality certification means that the management system meets the requirements imposed by International Standard ISO 9001:2015. The certification covers product development, production and sales.
Potential new immune-oncology therapy uses antibody drug conjugate (ADC) that targets regulatory T cells (Tregs)
iTeos Therapeutics SA today announced that management will participate in two upcoming conferences in November.
Auris Medical Holding AG today announced that it will provide a business update and report its financial results for the third quarter of 2018 on Thursday, November 15, 2018.
Kiadis Pharma N.V. today announces that it has appointed three new senior team members to further strengthen the Company as it transitions into commercial stage.
PRESS RELEASES